%0 Journal Article
%T ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway.
%A Wang B
%A Zhang XL
%A Li CX
%A Liu NN
%A Hu M
%A Gong ZC
%J Head Face Med
%V 17
%N 1
%D Jun 2021 3
%M 34082790
%F 2.246
%R 10.1186/s13005-021-00269-z
%X <B>BACKGROUND: </B>Oral cancer is a malignant disease that threatenshuman life and greatly reducespatientquality of life. ANLN was reported to promote the progression of cancer. This study aims to investigate the role of ANLNin oral cancer and the underlying molecular mechanism.<BR><B>METHODS: </B>ANLN expression was downregulated by RNAi technology. The effect of ANLN on cell behaviors, including proliferation, cell cycle progression, invasion, and apoptosis, was detected. Western blotting analysis was used to explore the mechanism by whichANLN functions in oral cancer.<BR><B>RESULTS: </B>Data from TCGA database showed that ANLN was expressed at significantly higher levels in tumor tissues thanin normal control tissues. Patients with higher ANLN expression exhibitedshorter survivaltimes. ANLN was alsoabundantly expressedin the cancer cell lines CAL27 and HN30. When ANLN was knocked down in CAL27 and HN30 cells, cell proliferation and colony formation weredecreased. The cell invasion ability was also inhibited. However, the cell apoptosis rate was increased. In addition, the levels of critical members of the PI3K signaling pathway, includingPI3K, mTOR, Akt, and PDK-1, were significantlyreducedafter ANLN was knocked down in CAL27 cells.<BR><B>CONCLUSIONS: </B>ANLN contributes to oral cancerprogressionand affects activation ofthe PI3K/mTOR signaling pathway. This study providesa new potential targetfor drug development and treatment in oral cancer.